(19)
(11) EP 4 815 973 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24816956.7

(22) Date of filing: 29.11.2024
(51) International Patent Classification (IPC): 
A61K 38/17(2006.01)
A61P 1/18(2006.01)
A61K 31/00(2006.01)
A61K 31/704(2006.01)
A61K 33/243(2019.01)
A61K 31/675(2006.01)
A61P 35/00(2006.01)
A61P 7/06(2006.01)
A61K 31/513(2006.01)
A61K 31/7048(2006.01)
G01N 33/50(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 38/17; A61P 35/00; A61P 7/06; A61P 1/18; A61K 31/704; A61K 31/7048; A61K 31/513; A61K 31/675; A61K 33/243; G01N 2800/52; C12Q 1/6886; C12Q 2600/158; C12Q 2600/118; G01N 33/57595
 
C-Sets:
  1. A61K 33/243, A61K 2300/00;
  2. A61K 31/704, A61K 2300/00;
  3. A61K 31/7048, A61K 2300/00;
  4. A61K 31/513, A61K 2300/00;
  5. A61K 31/675, A61K 2300/00;

(86) International application number:
PCT/EP2024/084049
(87) International publication number:
WO 2025/114512 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 29.11.2023 EP 23307082

(71) Applicants:
  • Centre National de la Recherche Scientifique
    75016 Paris (FR)
  • Université Toulouse III - Paul Sabatier
    31400 Toulouse (FR)
  • Institut National de la Santé et de la Recherche Médicale
    75013 Paris (FR)
  • UNIVERSITE CLAUDE BERNARD LYON 1
    69100 Villeurbanne (FR)
  • CENTRE LEON BERARD
    69008 Lyon (FR)

(72) Inventors:
  • LEBARON, Simon
    31062 TOULOUSE CEDEX 9 (FR)
  • TAGNERES, Sophie
    31062 TOULOUSE (FR)
  • GLEIZES, Pierre-Emmanuel
    31062 TOULOUSE CEDEX 9 (FR)
  • PLISSON-CHASTANG, Célia
    31062 TOULOUSE CEDEX 9 (FR)
  • MARCEL, Virginie
    69008 LYON (FR)

(74) Representative: Plasseraud IP 
104 Rue de Richelieu CS92104
75080 Paris Cedex 02
75080 Paris Cedex 02 (FR)

   


(54) THERAPEUTIC USE OF SURF2 MODULATORS